Yang Hyun Lee Selected Research

Yang Hyun Lee Research Topics

16	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2019
13	Dyskinesias (Dyskinesia) 01/2023 - 01/2019
11	Dementia (Dementias) 01/2023 - 01/2019
7	Cognitive Dysfunction 10/2021 - 01/2019
3	Lewy Body Disease (Lewy Body Dementia) 10/2021 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 07/2019
3	Parkinsonian Disorders (Parkinsonism) 01/2021 - 07/2019
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Disease Progression 11/2021
1	Sarcopenia 11/2021
1	Body Weight (Weight, Body) 11/2021
1	Hypokinesia (Bradykinesia) 01/2021
1	Cerebral Cortical Thinning 01/2020
1	Multiple System Atrophy 01/2020
1	Mental Disorders (Mental Disorder) 01/2017
1	Orthostatic Hypotension (Postural Hypotension) 01/2017

14	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 01/2019
9	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 05/2019
8	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2022 - 01/2020
4	Amyloid (Amyloid Fibrils)IBA 10/2021 - 01/2020
3	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 01/2021 - 07/2019
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021 - 07/2019
2	Neuroprotective AgentsIBA 01/2023 - 11/2021
2	Uric Acid (Urate)IBA 01/2020 - 01/2020
1	DihydropyridinesIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	CholesterolIBA 11/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Apolipoprotein E4IBA 10/2021
1	valrubicin (AD 32)FDA Link 01/2021
1	Donepezil (Aricept)FDA LinkGeneric 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017

1	Secondary Prevention 11/2021